These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 31029023)

  • 1. Monocytes-neutrophils-ratio as predictive marker for failure of first induction therapy in AML.
    Mika T; Ladigan S; Schork K; Turewicz M; Eisenacher M; Schmiegel W; Schroers R; Baraniskin A
    Blood Cells Mol Dis; 2019 Jul; 77():103-108. PubMed ID: 31029023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Routine interim disease assessment in patients undergoing induction chemotherapy for acute myeloid leukemia: Can we do better?
    Campuzano-Zuluaga G; Deutsch Y; Salzberg M; Gomez A; Vargas F; Elias R; Kwon D; Goodman M; Ikpatt OF; Chapman JR; Watts J; Vega F; Swords R
    Am J Hematol; 2016 Mar; 91(3):277-82. PubMed ID: 26663264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relation of clinical response and minimal residual disease and their prognostic impact on outcome in acute myeloid leukemia.
    Chen X; Xie H; Wood BL; Walter RB; Pagel JM; Becker PS; Sandhu VK; Abkowitz JL; Appelbaum FR; Estey EH
    J Clin Oncol; 2015 Apr; 33(11):1258-64. PubMed ID: 25732155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrating resistance functions to predict response to induction chemotherapy in de novo acute myeloid leukemia.
    Chiu YC; Hsiao TH; Tsai JR; Wang LJ; Ho TC; Hsu SL; Teng CJ
    Eur J Haematol; 2019 Oct; 103(4):417-425. PubMed ID: 31356696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adult acute leukemia.
    Cripe LD
    Curr Probl Cancer; 1997; 21(1):1-64. PubMed ID: 9058027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of preleukemic mutations and their persistence on hematologic recovery after induction chemotherapy for AML.
    Murphy T; Zou J; Daher-Reyes GS; Arruda A; Gupta V; McNamara CJ; Minden MD; Schimmer AD; Sibai H; Yee KWL; Korulla M; Stockley T; Kamel-Reid S; Maze D; Tierens A; Bratman SV; Schuh AC; Chan SM
    Blood Adv; 2019 Aug; 3(15):2307-2311. PubMed ID: 31371380
    [No Abstract]   [Full Text] [Related]  

  • 7. Correlative patterns of neutrophil and platelet counts during very early remission of acute myeloblastic leukemia.
    Ventura GJ; Drewinko B; Keating MJ
    Hematol Pathol; 1987; 1(2):113-6. PubMed ID: 3504433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic and therapeutic implications of early treatment response assessment in acute myeloid leukemia.
    Pullarkat V; Aldoss I
    Crit Rev Oncol Hematol; 2015 Jul; 95(1):38-45. PubMed ID: 25624175
    [TBL] [Abstract][Full Text] [Related]  

  • 9. White Blood Cell Count Nadir and Duration of Aplasia Do Not Associate with Treatment Outcome in Adult Patients with Acute Myeloid Leukemia Undergoing Intensive Chemotherapy.
    Marras T; Dettori M; Caocci G; La Nasa G; Sotgiu G; Saderi L; Fozza C
    Chemotherapy; 2020; 65(3-4):110-114. PubMed ID: 32950983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia.
    Minakata D; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Int J Hematol; 2017 Sep; 106(3):411-417. PubMed ID: 28508228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is the D14 bone marrow in acute myeloid leukemia still the gold standard?
    Ofran Y
    Curr Opin Hematol; 2016 Mar; 23(2):108-14. PubMed ID: 26717195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resource Utilization and Safety of Outpatient Management Following Intensive Induction or Salvage Chemotherapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome: A Nonrandomized Clinical Comparative Analysis.
    Vaughn JE; Othus M; Powell MA; Gardner KM; Rizzuto DL; Hendrie PC; Becker PS; Pottinger PS; Estey EH; Walter RB
    JAMA Oncol; 2015 Nov; 1(8):1120-7. PubMed ID: 26355382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early recovery of the platelet count after decitabine-based induction chemotherapy is a prognostic marker of superior response in elderly patients with newly diagnosed acute myeloid leukaemia.
    Huang J; Zhao H; Hong M; Zhu H; Zhu Y; Lian Y; Li S; Li J; Qian S
    BMC Cancer; 2018 Dec; 18(1):1269. PubMed ID: 30567513
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regimen-intensity per count-recovery and hospitalization index: A new tool to assign regimen intensity for AML.
    Sorror ML; Agarwal S; Othus M; Lynch Y; Nyland JE; Percival ME; Becker PS; Appelbaum FR; Estey EH
    Cancer Med; 2020 Sep; 9(18):6515-6523. PubMed ID: 32706528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current and emerging therapies for acute myeloid leukemia.
    Robak T; Wierzbowska A
    Clin Ther; 2009; 31 Pt 2():2349-70. PubMed ID: 20110045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic significance of rapid peripheral blood blast clearance during the initial course of induction chemotherapy in young patients with de novo acute myeloid leukemia.
    Nakano H; Fujiwara SI; Ito S; Mashima K; Umino K; Minakata D; Yamasaki R; Kawasaki Y; Sugimoto M; Ashizawa M; Yamamoto C; Hatano K; Okazuka K; Sato K; Oh I; Ohmine K; Suzuki T; Muroi K; Kanda Y
    Hematol Oncol; 2017 Sep; 35(3):357-364. PubMed ID: 26639319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive and Prognostic Markers in Adults With Acute Myeloid Leukemia: A Single-Institution Experience.
    Gbadamosi B; Ezekwudo D; Bastola S; Jaiyesimi I
    Clin Lymphoma Myeloma Leuk; 2018 Jul; 18(7):e287-e294. PubMed ID: 29803615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kinetics and apoptotic profile of circulating endothelial cells as prognostic factors for induction treatment failure in newly diagnosed acute myeloid leukemia patients.
    Wierzbowska A; Robak T; Krawczyńska A; Pluta A; Wrzesień-Kuś A; Cebula B; Robak E; Smolewski P
    Ann Hematol; 2008 Feb; 87(2):97-106. PubMed ID: 17849117
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II study.
    Wielenga JJ; Vellenga E; Groenewegen A; Sonneveld P; Löwenberg B
    Leukemia; 1996 Jan; 10(1):43-7. PubMed ID: 8558936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-treatment with oral hydroxyurea prior to intensive chemotherapy improves early survival of patients with high hyperleukocytosis in acute myeloid leukemia.
    Mamez AC; Raffoux E; Chevret S; Lemiale V; Boissel N; Canet E; Schlemmer B; Dombret H; Azoulay E; Lengliné E
    Leuk Lymphoma; 2016 Oct; 57(10):2281-8. PubMed ID: 26849624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.